Literature DB >> 27698630

Longitudinal Outcomes Following a Randomized Controlled Trial of Dynamic Splint Stretching for Carpal Tunnel Syndrome.

F Buck Willis1, Brook Fowler2.   

Abstract

Background: The incidence of carpal tunnel syndrome (CTS) is 48 million patients in the United States. The purpose of this longitudinal study was to determine whether Dynasplint stretching (immediately after diagnosis) had an effect on a patient's decision to seek surgical treatment for CTS.
Methods: Fifty patients (10 men, 40 women, mean age 51.2 ± 12 years) were recruited for this randomized, controlled, longitudinal trial. Patients were diagnosed with CTS by physical examination and nerve conduction studies. The intervention used was Dynasplint stretching that delivered a prolonged duration of low load stretching. Patients who were randomly chosen for the Experimental category wore the device for two 30-minute sessions per day with regular increases in splint tension for 60 days. Control patients received nonsteroidal anti-inflammatory medication plus instructions on daily home stretching.
Results: The final, longitudinal outcome showed a 72% reduction in surgery chosen by the experimental group (n = 25), compared with 38% reduction for control patients (n = 25). Conclusions: Immediate treatment with Dynasplint stretching showed a 2 to 1 reduction in surgery, with abundant financial savings.

Entities:  

Keywords:  Dynasplint; contracture reduction; home therapy; pain management

Mesh:

Substances:

Year:  2016        PMID: 27698630      PMCID: PMC5030854          DOI: 10.1177/1558944715626925

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  25 in total

Review 1.  Clinical practice. Carpal tunnel syndrome.

Authors:  Jeffrey N Katz; Barry P Simmons
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

2.  Time course and predictors of median nerve conduction after carpal tunnel release.

Authors:  Mitchell B Rotman; Bobby V Enkvetchakul; J Thomas Megerian; Shai N Gozani
Journal:  J Hand Surg Am       Date:  2004-05       Impact factor: 2.230

3.  The impact of procedure type, jurisdiction and other factors in workers' compensation on work-disability outcomes following carpal tunnel surgery.

Authors:  Radoslaw Wasiak; Glenn Pransky
Journal:  Work       Date:  2007

4.  Efficacy of splinting and oral steroids in the treatment of carpal tunnel syndrome: a prospective randomized clinical and electrophysiological study.

Authors:  Sanjay Mishra; Sudesh Prabhakar; Vivek Lal; Manish Modi; Chandi P Das; Dheeraj Khurana
Journal:  Neurol India       Date:  2006-09       Impact factor: 2.117

5.  Surgery versus conservative therapy in carpal tunnel syndrome in people aged 70 years and older.

Authors:  Anke M Ettema; Peter C Amadio; Stephen S Cha; Jeffrey R Harrington; Ann M Harris; Kenneth P Offord
Journal:  Plast Reconstr Surg       Date:  2006-09-15       Impact factor: 4.730

6.  Prevalence of carpal tunnel syndrome in a general population.

Authors:  I Atroshi; C Gummesson; R Johnsson; E Ornstein; J Ranstam; I Rosén
Journal:  JAMA       Date:  1999-07-14       Impact factor: 56.272

7.  Outcomes of carpal tunnel surgery with and without supervised postoperative therapy.

Authors:  Jay Pomerance; Ilene Fine
Journal:  J Hand Surg Am       Date:  2007-10       Impact factor: 2.230

8.  Effects of wrist splinting for Carpal Tunnel syndrome and motor nerve conduction measurements.

Authors:  Shingo Nobuta; Katsumi Sato; Tomowaki Nakagawa; Masahito Hatori; Eiji Itoi
Journal:  Ups J Med Sci       Date:  2008       Impact factor: 2.384

Review 9.  Carpal tunnel syndrome and its relation to occupation: a systematic literature review.

Authors:  Keith T Palmer; E Clare Harris; David Coggon
Journal:  Occup Med (Lond)       Date:  2006-11-02       Impact factor: 1.611

Review 10.  Systematic review of contracture reduction in the lower extremity with dynamic splinting.

Authors:  John P Furia; F Buck Willis; Ram Shanmugam; Sarah A Curran
Journal:  Adv Ther       Date:  2013-09-10       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.